Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-20-043004
Filing Date
2020-12-16
Accepted
2020-12-16 16:05:32
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_citiuspharma.htm 10-K 1066120
2 LICENSE AGREEMENT, DATED OCTOBER 6, 2020, BETWEEN NOVECITE, INC. AND NOVELLUS TH f10k2020ex10-24_citius.htm EX-10.24 413257
3 SUBSIDIARIES f10k2020ex21_citius.htm EX-21 9169
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2020ex23-1_citius.htm EX-23.1 3757
5 CERTIFICATION f10k2020ex31-1_citius.htm EX-31.1 12651
6 CERTIFICATION f10k2020ex31-2_citius.htm EX-31.2 12994
7 CERTIFICATION f10k2020ex32-1_citius.htm EX-32.1 7144
  Complete submission text file 0001213900-20-043004.txt   4414796

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE ctxr-20200930.xml EX-101.INS 484751
9 XBRL SCHEMA FILE ctxr-20200930.xsd EX-101.SCH 56739
10 XBRL CALCULATION FILE ctxr-20200930_cal.xml EX-101.CAL 43937
11 XBRL DEFINITION FILE ctxr-20200930_def.xml EX-101.DEF 164067
12 XBRL LABEL FILE ctxr-20200930_lab.xml EX-101.LAB 340713
13 XBRL PRESENTATION FILE ctxr-20200930_pre.xml EX-101.PRE 261847
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38174 | Film No.: 201392479
SIC: 2834 Pharmaceutical Preparations